Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleftherios Mylonakis

Showing results (1-10 of 451) with videos related to

Pageof 46
Sort By:
Rhode Island Medical Journal (2013)|August 2, 2021
SARS-CoV-2 Variants and their Clinical ImplicationsEleftherios Mylonakis
Current Pharmaceutical Design|April 8, 2011
The need to redefine antimicrobial drug discoveryEleftherios Mylonakis
Rhode Island Medical Journal (2013)|July 14, 2022
SARS-CoV-2 Variants and Their Clinical Significance: An Update as of May 2022Eleftherios Mylonakis
Mycopathologia|December 7, 2007
Galleria mellonella and the study of fungal pathogenesis: making the case for another genetically tractable model hostEleftherios Mylonakis
Infection and Immunity|June 24, 2005
Worms and flies as genetically tractable animal models to study host-pathogen interactionsEleftherios Mylonakis, Alejandro Aballay
Infection and Immunity|May 16, 2012
Caenorhabditis elegans immune conditioning with the probiotic bacterium Lactobacillus acidophilus strain NCFM enhances gram-positive immune responsesYounghoon Kim, Eleftherios Mylonakis
Cell Reports|September 7, 2017
An Intestine-Derived Neuropeptide Controls Avoidance Behavior in Caenorhabditis elegansKiho Lee, Eleftherios Mylonakis
Virulence|December 17, 2014
Effector triggered immunityRajmohan Rajamuthiah, Eleftherios Mylonakis
Expert Opinion on Drug Discovery|January 16, 2026
Advances in methicillin-resistant <i>staphylococcus aureus</i> drug discovery: developments and challengesStephanos Vassilopoulos, Eleftherios Mylonakis
Annals of Internal Medicine|May 19, 2020
In utero exposure to systemic antibiotics vs reference penicillins was not linked to congenital malformationsEleftheria Atalla, Eleftherios Mylonakis
Pageof 46

Showing results (1-10 of 451) with videos related to

Sort By:
Pageof 46
Rhode Island Medical Journal (2013)|August 2, 2021
SARS-CoV-2 Variants and their Clinical ImplicationsEleftherios Mylonakis
Current Pharmaceutical Design|April 8, 2011
The need to redefine antimicrobial drug discoveryEleftherios Mylonakis
Rhode Island Medical Journal (2013)|July 14, 2022
SARS-CoV-2 Variants and Their Clinical Significance: An Update as of May 2022Eleftherios Mylonakis
Mycopathologia|December 7, 2007
Galleria mellonella and the study of fungal pathogenesis: making the case for another genetically tractable model hostEleftherios Mylonakis
Infection and Immunity|June 24, 2005
Worms and flies as genetically tractable animal models to study host-pathogen interactionsEleftherios Mylonakis, Alejandro Aballay
Infection and Immunity|May 16, 2012
Caenorhabditis elegans immune conditioning with the probiotic bacterium Lactobacillus acidophilus strain NCFM enhances gram-positive immune responsesYounghoon Kim, Eleftherios Mylonakis
Cell Reports|September 7, 2017
An Intestine-Derived Neuropeptide Controls Avoidance Behavior in Caenorhabditis elegansKiho Lee, Eleftherios Mylonakis
Virulence|December 17, 2014
Effector triggered immunityRajmohan Rajamuthiah, Eleftherios Mylonakis
Expert Opinion on Drug Discovery|January 16, 2026
Advances in methicillin-resistant <i>staphylococcus aureus</i> drug discovery: developments and challengesStephanos Vassilopoulos, Eleftherios Mylonakis
Annals of Internal Medicine|May 19, 2020
In utero exposure to systemic antibiotics vs reference penicillins was not linked to congenital malformationsEleftheria Atalla, Eleftherios Mylonakis
Pageof 46